![Efficacy of RISPERDAL CONSTA® — 52-Week Adjunctive Therapy Trial— RISPERDAL CONSTA® (risperidone) LONG-ACTING INJECTION Efficacy of RISPERDAL CONSTA® — 52-Week Adjunctive Therapy Trial— RISPERDAL CONSTA® (risperidone) LONG-ACTING INJECTION](https://www.risperdalconstahcp.com/sites/default/files/img/risperdal/img-efficacy-1b.png)
Efficacy of RISPERDAL CONSTA® — 52-Week Adjunctive Therapy Trial— RISPERDAL CONSTA® (risperidone) LONG-ACTING INJECTION
![Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials | Molecular Psychiatry Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41380-020-00946-6/MediaObjects/41380_2020_946_Fig1_HTML.png)
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials | Molecular Psychiatry
Drug Treatments for Acute Mania - Treatment for Bipolar Disorder in Adults: A Systematic Review - NCBI Bookshelf
![Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial | Molecular Psychiatry Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial | Molecular Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmp.2015.158/MediaObjects/41380_2016_Article_BFmp2015158_Fig1_HTML.jpg)
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial | Molecular Psychiatry
![Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety | American Journal of Psychiatry Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.159.7.1146/asset/images/medium/k611t1.jpeg)
Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety | American Journal of Psychiatry
![Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180613111343828-0321:S000712500026978X:S000712500026978X_tab3.gif?pub-status=live)
Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core
![Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180613111343828-0321:S000712500026978X:S000712500026978X_tab2.gif?pub-status=live)
Mood stabilisers plus risperidone or placebo in the treatment of acute mania | The British Journal of Psychiatry | Cambridge Core
![Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety | American Journal of Psychiatry Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.159.7.1146/asset/images/medium/k611f2.jpeg)